![Cytarabine (cytosine arabinoside, Ara-C) chemotherapy drug molecule. Used in treatment of acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL) and lymphoma. Skeletal formula. Stock Illustration | Adobe Stock Cytarabine (cytosine arabinoside, Ara-C) chemotherapy drug molecule. Used in treatment of acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL) and lymphoma. Skeletal formula. Stock Illustration | Adobe Stock](https://as2.ftcdn.net/v2/jpg/01/87/81/49/1000_F_187814900_030z9cw3hZWMsn5bva1i7hIJ4m7PrtBh.jpg)
Cytarabine (cytosine arabinoside, Ara-C) chemotherapy drug molecule. Used in treatment of acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL) and lymphoma. Skeletal formula. Stock Illustration | Adobe Stock
![Molecules | Free Full-Text | Exploring the Antitumor Mechanism of High-Dose Cytarabine through the Metabolic Perturbations of Ribonucleotide and Deoxyribonucleotide in Human Promyelocytic Leukemia HL-60 Cells Molecules | Free Full-Text | Exploring the Antitumor Mechanism of High-Dose Cytarabine through the Metabolic Perturbations of Ribonucleotide and Deoxyribonucleotide in Human Promyelocytic Leukemia HL-60 Cells](https://www.mdpi.com/molecules/molecules-22-00499/article_deploy/html/images/molecules-22-00499-g001.png)
Molecules | Free Full-Text | Exploring the Antitumor Mechanism of High-Dose Cytarabine through the Metabolic Perturbations of Ribonucleotide and Deoxyribonucleotide in Human Promyelocytic Leukemia HL-60 Cells
![Cytarabine Cytosine Arabinoside Arac Molecule It Is Chemotherapy Medication Skeletal Chemical Formula Paper Packaging For Drugs Stock Illustration - Download Image Now - iStock Cytarabine Cytosine Arabinoside Arac Molecule It Is Chemotherapy Medication Skeletal Chemical Formula Paper Packaging For Drugs Stock Illustration - Download Image Now - iStock](https://media.istockphoto.com/id/1481921853/vector/cytarabine-cytosine-arabinoside-ara-c-molecule-it-is-chemotherapy-medication-skeletal.jpg?s=612x612&w=0&k=20&c=WuLSXh-Dr1aRhBOKByLv9kBXgjEvQynpHq4O7ZEbzG0=)
Cytarabine Cytosine Arabinoside Arac Molecule It Is Chemotherapy Medication Skeletal Chemical Formula Paper Packaging For Drugs Stock Illustration - Download Image Now - iStock
![Cytarabine Cytosine Arabinoside Arac Molecule It Is Chemotherapy Medication Structural Chemical Formula And Molecule Model Stock Illustration - Download Image Now - iStock Cytarabine Cytosine Arabinoside Arac Molecule It Is Chemotherapy Medication Structural Chemical Formula And Molecule Model Stock Illustration - Download Image Now - iStock](https://media.istockphoto.com/id/1481921315/vector/cytarabine-cytosine-arabinoside-ara-c-molecule-it-is-chemotherapy-medication-structural.jpg?s=612x612&w=is&k=20&c=aJOppeGlsXYD-L8PzLfp_mJWWxsiggoQ203pV7A1wAc=)
Cytarabine Cytosine Arabinoside Arac Molecule It Is Chemotherapy Medication Structural Chemical Formula And Molecule Model Stock Illustration - Download Image Now - iStock
![Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death | BMC Cancer | Full Text Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-07701-8/MediaObjects/12885_2020_7701_Fig1_HTML.png)
Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death | BMC Cancer | Full Text
![Cytarabine (cytosine arabinoside, Ara-C) chemotherapy drug molecule. Used in treatment of acute myeloid leukemia (AML), acute lymphocytic leukemia (AL Stock Vector Image & Art - Alamy Cytarabine (cytosine arabinoside, Ara-C) chemotherapy drug molecule. Used in treatment of acute myeloid leukemia (AML), acute lymphocytic leukemia (AL Stock Vector Image & Art - Alamy](https://c8.alamy.com/comp/KXYGR0/cytarabine-cytosine-arabinoside-ara-c-chemotherapy-drug-molecule-used-KXYGR0.jpg)
Cytarabine (cytosine arabinoside, Ara-C) chemotherapy drug molecule. Used in treatment of acute myeloid leukemia (AML), acute lymphocytic leukemia (AL Stock Vector Image & Art - Alamy
![Bilateral Ear Swelling and Erythema after Chemotherapy: A Case Report of Ara -C Ears | Semantic Scholar Bilateral Ear Swelling and Erythema after Chemotherapy: A Case Report of Ara -C Ears | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/fd63eb214ea90b377cbaa2b0d0bda2b9548b23ae/7-Figure3-1.png)
Bilateral Ear Swelling and Erythema after Chemotherapy: A Case Report of Ara -C Ears | Semantic Scholar
![Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death | BMC Cancer | Full Text Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-07701-8/MediaObjects/12885_2020_7701_Fig4_HTML.png)
Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death | BMC Cancer | Full Text
![Cytarabine (cytosine arabinoside, Ara-C) chemotherapy drug molecule. Used in treatment of acute myeloid leukemia (AML), etc Stock Photo - Alamy Cytarabine (cytosine arabinoside, Ara-C) chemotherapy drug molecule. Used in treatment of acute myeloid leukemia (AML), etc Stock Photo - Alamy](https://c8.alamy.com/comp/DXB96C/cytarabine-cytosine-arabinoside-ara-c-chemotherapy-drug-molecule-used-DXB96C.jpg)
Cytarabine (cytosine arabinoside, Ara-C) chemotherapy drug molecule. Used in treatment of acute myeloid leukemia (AML), etc Stock Photo - Alamy
![Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial - The Lancet Haematology Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial - The Lancet Haematology](https://www.thelancet.com/cms/attachment/a29bdb5a-d820-4340-a9ee-aad2751e2b3d/gr1_lrg.gif)
Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial - The Lancet Haematology
![Cytarabine or cytosine arabinoside is a chemotherapy medication used to treat acute myeloid leukemia, acute lymphocytic leukemia, chronic myelogenous Stock Photo - Alamy Cytarabine or cytosine arabinoside is a chemotherapy medication used to treat acute myeloid leukemia, acute lymphocytic leukemia, chronic myelogenous Stock Photo - Alamy](https://l450v.alamy.com/450v/2jgwe5p/cytarabine-cytosine-arabinoside-ara-c-molecule-it-is-chemotherapy-medication-molecular-model-3d-rendering-illustration-2jgwe5p.jpg)
Cytarabine or cytosine arabinoside is a chemotherapy medication used to treat acute myeloid leukemia, acute lymphocytic leukemia, chronic myelogenous Stock Photo - Alamy
![Cytarabine nanotherapeutics with increased stability and enhanced lymphoma uptake for tailored highly effective therapy of mantle cell lymphoma - ScienceDirect Cytarabine nanotherapeutics with increased stability and enhanced lymphoma uptake for tailored highly effective therapy of mantle cell lymphoma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1742706120306577-fx1.jpg)
Cytarabine nanotherapeutics with increased stability and enhanced lymphoma uptake for tailored highly effective therapy of mantle cell lymphoma - ScienceDirect
![Cytarabine (cytosine arabinoside, Ara-C) chemotherapy drug molecule. Used in treatment of acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL) and lymphoma. Conventional skeletal formula and stylized representations.:: موقع تصميمي Cytarabine (cytosine arabinoside, Ara-C) chemotherapy drug molecule. Used in treatment of acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL) and lymphoma. Conventional skeletal formula and stylized representations.:: موقع تصميمي](https://images.assetsdelivery.com/compings_v2/molekuul/molekuul1412/molekuul141200173.jpg)
Cytarabine (cytosine arabinoside, Ara-C) chemotherapy drug molecule. Used in treatment of acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL) and lymphoma. Conventional skeletal formula and stylized representations.:: موقع تصميمي
![When chemotherapy interrupts genetic programs critical for neuronal development and activity, cells accrue DNA damage and die | Center for Cancer Research When chemotherapy interrupts genetic programs critical for neuronal development and activity, cells accrue DNA damage and die | Center for Cancer Research](https://ccr.cancer.gov/sites/default/files/2022-12/Nussenzweig_Nov2022.jpg)
When chemotherapy interrupts genetic programs critical for neuronal development and activity, cells accrue DNA damage and die | Center for Cancer Research
![Structural insights into mutagenicity of anticancer nucleoside analog cytarabine during replication by DNA polymerase η | Scientific Reports Structural insights into mutagenicity of anticancer nucleoside analog cytarabine during replication by DNA polymerase η | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-52703-7/MediaObjects/41598_2019_52703_Fig1_HTML.png)
Structural insights into mutagenicity of anticancer nucleoside analog cytarabine during replication by DNA polymerase η | Scientific Reports
![Novel immunomodulatory properties of low dose cytarabine entrapped in a mannosylated cationic liposome - ScienceDirect Novel immunomodulatory properties of low dose cytarabine entrapped in a mannosylated cationic liposome - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0378517321006542-ga1.jpg)
Novel immunomodulatory properties of low dose cytarabine entrapped in a mannosylated cationic liposome - ScienceDirect
![Mathematical Models for the Influence of Cytarabine on White Blood Cell Dynamics in Acute Myeloid Leukemia | bioRxiv Mathematical Models for the Influence of Cytarabine on White Blood Cell Dynamics in Acute Myeloid Leukemia | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2018/09/27/428326/F1.large.jpg)
Mathematical Models for the Influence of Cytarabine on White Blood Cell Dynamics in Acute Myeloid Leukemia | bioRxiv
![High-Dose Methotrexate and Cytarabine-Based Multi-Agent Chemotherapy (Modified Bonn Protocol) for Systemic Lymphoma with CNS Involvement | Semantic Scholar High-Dose Methotrexate and Cytarabine-Based Multi-Agent Chemotherapy (Modified Bonn Protocol) for Systemic Lymphoma with CNS Involvement | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/67d5b8c7c7aa48b419e1e719f0164ffccc382b80/2-Table1-1.png)
High-Dose Methotrexate and Cytarabine-Based Multi-Agent Chemotherapy (Modified Bonn Protocol) for Systemic Lymphoma with CNS Involvement | Semantic Scholar
![Cancers | Free Full-Text | Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers Cancers | Free Full-Text | Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers](https://www.mdpi.com/cancers/cancers-13-00966/article_deploy/html/images/cancers-13-00966-g001.png)